November 19, 2024

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults vs Older Adults?

Young patients living with colon or colorectal cancer have long-term, adverse consequences on their lives, which are different from the impact the disease has on older adults, according to two studies...

The ASCO Post

November 15, 2024

Detecting Evidence of Lung Cancer in Exhaled Breath

Researchers may have developed ultrasensitive, nanoscale sensors that distinguished a key change in the chemistry of the breath of patients with lung cancer.

The ASCO Post

November 14, 2024

From Gaps to Bridges: Cancer Care Rooted in Equity, Quality, and Value

“Inequities are a major obstacle in delivering safe, timely, respectful, and affordable cancer care globally,” commented moderator John Varallo, MD, MPH, FACOG, of the Global Surgery Foundation, at th...

The ASCO Post

November 12, 2024

SITC: Study Finds IO102-IO103 Vaccine Plus Pembrolizumab Active in Patients With Non–Small Cell Lung Cancer

To be presented at the 2024 Society for Immunotherapy of Cancer Annual Meeting, a phase II study by Riess et al investigating the IO102-IO103 vaccine plus pembrolizumab as first-line treatment in pati...

The ASCO Post

November 11, 2024

Neoadjuvant Therapy Yields Notable Outcomes in Triple-Negative Breast Cancer

The studies summarized here were reported online over the past month in The ASCO Post, generating a high number of visitors. For comprehensive news of these studies and more, visit ASCOPost.com.

The ASCO Post

November 08, 2024

Advancing Diversity, Equity, and Inclusion Through a Challenging Policy Landscape

Experts assembled in Washington, DC, to participate in the NCCN Oncology Policy Summit: Advancing Diversity, Equity, and Inclusion in the Cancer Workforce. During the second panel discussion of the da...

The ASCO Post

November 08, 2024

Ensuring an Inclusive Environment for Female Minority Oncologists

Acts of discrimination by her superiors and colleagues at an academic cancer center in New York City prompted Coral Olazagasti, MD, a native of Puerto Rico, to launch a study examining gender disparit...

The ASCO Post

November 08, 2024

A Diagnosis of Lymphoma Has Changed My Life

“I was 35 when I was told that I had CD20-positive Hodgkin lymphoma. My oncologist assured me that although the disease was rare, it was treatable—and even curable. With the memory of my dying father ...

The ASCO Post

November 08, 2024

HypoG-01 Trial: Reducing the Treatment Time for Breast Cancer Nodal Irradiation

A 3-week moderately hypofractionated radiotherapy regimen has been found to be noninferior to the 5-week fractionation when irradiating nodal areas in patients with breast cancer, according to data pr...

The ASCO Post